Document is current
Any future updates will be listed below
-
Authors
Seybert, Carolina http://orcid.org/0000-0003-4028-5648
Cotovio, Gonçalo
Madeira, Luís
Ricou, Miguel http://orcid.org/0000-0002-8190-9587
Pires, Ana Matos
Oliveira-Maia, Albino J.
- License Information
-
More Information
Article History
First Online: 14 June 2023
Competing interests
: C.S. received payment from the European Monitoring Centre for Drugs and Drug Addiction. A.M.P. received payment or honoraria from Janssen and Lundbeck and participated in advisory boards for Janssen and Angelini. A.J.O.-M. was the national coordinator for Portugal of trials for treatment-resistant depression of psilocybin, sponsored by Compass Pathways, Ltd (EudraCT number 2017-003288-36), and of esketamine, sponsored by Janssen-Cilag, Ltd (EudraCT NUMBER: 2019-002992-33); received payment or honoraria from MSD, Neurolite AG, Janssen and the European Monitoring Centre for Drugs and Drug Addiction; participated in advisory boards for Janssen and Angelini; and is the recipient of a grant from Schuhfried GmBH. The remaining authors declare no competing interests.
